Literature DB >> 17027754

Effects of latanoprost on rodent intraocular pressure.

Shahid Husain1, N Andy Whitlock, Dennis S Rice, Craig E Crosson.   

Abstract

The aim of the present study was to evaluate the effects of the prostaglandin F2 alpha analog, latanoprost, on the intraocular pressure (IOP) in rodent eyes. Rodents have been increasingly used in glaucoma research; however, conflicting results regarding the actions of prostaglandins on rodent IOP have been published. In Wistar rats, a single dose of latanoprost (60 ng) produced a biphasic change in IOP: an initial rise in pressure (2.1+/-0.7 mmHg) peaking at 2 h, followed by a prolonged hypotension with a peak reduction in IOP (5.2+/-0.7 mmHg) at 5 h. Both the hyper and hypotensive actions of latanoprost were dose-related with ED50 values of 108 and 5.2 ng, respectively. These responses were antagonized by pretreatment with 4% pilocarpine. In Brown Norway rats and C57BL/6 mice, a single dose of latanoprost also produced a biphasic response in IOP with an initial rise in pressure peaking between 1 and 2 h, followed by prolonged hypotension from 4 to 8 h. These results demonstrate that in rodents the IOP response to topical latanoprost is characterized by an initial hypertension followed by a prolonged hypotension. This prolonged hypotension is similar to that measured in monkeys and humans. Taken together, these results support the idea that rodents can serve as in vivo models to study the actions of ocular hypotensive agents, such as prostaglandins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027754     DOI: 10.1016/j.exer.2006.08.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  12 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma.

Authors:  Qiang Yang; Kin-Sang Cho; Huihui Chen; Dekuang Yu; Wan-Heng Wang; Gang Luo; Iok-Hou Pang; Wenyi Guo; Dong Feng Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

3.  Latanoprost-induced changes in rat intraocular pressure: direct or indirect?

Authors:  Shahid Husain; Phillip W Yates; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

4.  Bestrophin-2 is involved in the generation of intraocular pressure.

Authors:  Benjamin Bakall; Precious McLaughlin; J Brett Stanton; Youwen Zhang; H Criss Hartzell; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

5.  Barrier qualities of the mouse eye to topically applied drugs.

Authors:  Zhao Wang; Chi Wai Do; Marcel Y Avila; Richard A Stone; Kenneth A Jacobson; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2007-03-24       Impact factor: 3.467

6.  Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.

Authors:  Yasir Abdul; Naseem Akhter; Shahid Husain
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

7.  Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice.

Authors:  Youwen Zhang; Bryan R Davidson; W Daniel Stamer; Jennifer K Barton; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

Review 8.  Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Authors:  Carol B Toris; B'Ann T Gabelt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

9.  Evaluation of monkey intraocular pressure by rebound tonometer.

Authors:  Wenhan Yu; Guiqun Cao; Jinghua Qiu; Xuyang Liu; Jia Ma; Ni Li; Man Yu; Naihong Yan; Lei Chen; Iok-Hou Pang
Journal:  Mol Vis       Date:  2009-10-27       Impact factor: 2.367

10.  Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study.

Authors:  Alex L C Tam; Neeru Gupta; Zhexue Zhang; Yeni H Yücel
Journal:  Transl Vis Sci Technol       Date:  2013-08-07       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.